Stories about Medizin, Gesundheit
- 5One documentmore
Adragos Pharma acquires Clinigen’s development unit, Lamda Laboratories
Munich / London / Athens (ots) - - Acquisition strengthens Adragos end-to-end integrated service offering within the pharmaceutical product development segment - Agreement includes further product development activities for Clinigen Limited - Lamda spurs further growth for Adragos as its 3rd site in Europe, and 5th globally Munich-based pharmaceutical contract ...
moreThe world's first Extended Isolated Stopflow Limb Infusion (EISLI) to treat osteosarcoma results in complete remission
moreSuccessful transaction: Adragos Pharma has officially taken over the Sanofi production site in Kawagoe, Japan
Munich / Paris / Tokyo (ots) - - Adragos Pharma now third largest pure-play CDMO in the Japanese market - Long-term agreement with Sanofi secures local healthcare supply Munich-based pharmaceutical contract manufacturer (CDMO) Adragos Pharma GmbH successfully completed the acquisition of one of Japan's leading ...
moreInnovation and Start-up Center Biotechnology (IZB) welcomes Invitris
One documentmoreMadeira's public health service SESARAM, EPERAM cooperates with EU project Smart4Health
Potsdam (Germany) (ots) - - Over 260,000 residents and travelers to Madeira Islands can use the digital health solution free of charge - Easy access to healthcare data from the public healthcare services, via a European electronic health record - the Smart4Health platform The Public Health Service of the Autonomous Region of Madeira - SESARAM, EPERAM - has successfully ...
more
Blood Donation Day at R-Biopharm: Employees Help Save Lives
moreBreakthrough - EUR 50 million investment for start-up BrainRepair UG / Pivotal trial on stem cell treatment for brain damage in newborns fully funded
more- 4
PM-International donates €1,872,000 to charity sponsoring 5,200 children around the world
more CO.DON finally saved - investor has taken over the business operations of the Leipzig-based biopharmacy company with an additional location in Teltow, Brandenburg
Leipzig / Teltow (ots) - CO.DON continues business operations as a GmbH (limited liability company) With effect from 20.01.2023, CO.DON's business activities will be continued in the legal form of a GmbH (limited liability company) following a transferring reorganisation. The asset deal with Rejuvenate GmbH, a ...
moreCES 2023 “Best of Innovation” Award winner German Bionic presents new generation of smart power suits and wearables for safe workplaces
moreCanada, the largest importer of EU lemon outside of Europe
more
LectureLinx and PAYCE Announce a Global Expansion Through a Worldwide Exclusive Licensing Agreement to Combine Technologies and Services for the Pharmaceutical Industry
BRANFORD, CONN (ots) - --News Direct-- LectureLinx, a leader in compliance technologies for the pharmaceutical and life science industries, and PAYCE, a leading pharmaceutical technology provider for healthcare professionals (HCPs) and healthcare organizations (HCOs) in Europe, have agreed to an exclusive global ...
moreTechnische Universität München
New X-ray technology can improve Covid-19 diagnosis
TECHNICAL UNIVERSITY OF MUNICHCorporate Communications Center phone: +49 89 289 22798 - email: presse@tum.de - web: www.tum.de Images: https://mediatum.ub.tum.de/1692790 NEWS RELEASE New X-ray technology can improve Covid-19 diagnosis Patient study demonstrates benefits of dark-field X-ray technology A research team at the Technical University of Munich (TUM) has, for the first time, produced dark-field X-ray images of ...
moreWhat are the benefits of drinking lemon juice on an empty stomach to our body?
moreTechnische Universität München
Why are overweight people more susceptible to illness?
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22778 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/en/news-and-events/all-news/press-releases/details/warum-bekommen-uebergewichtige-menschen-haeufiger-erkrankungen Picture: https://mediatum.ub.tum.de/1612044 NEWS RELEASE Why are overweight people more susceptible to illness? Size of fat cells can cause ...
moreVectorBuilder Won First Prize in Major Innovation Competition
Chicago, IL (ots) - --News Direct-- VectorBuilder Inc. – a global leader in gene delivery technologies – announced that its R&D and manufacturing center in Guangzhou won championship in the 7th “Chuangke Innovation and Entrepreneurship Global Competition” held in Hangzhou, China. This influential and highly competitive contest is one of the largest in China, covering growth-stage enterprises across all high-tech ...
moreTechnische Universität München
Nanoswitches for tumor targeting
TECHNICAL UNIVERSITY OF MUNICHCorporate Communications Center phone: +49 89 289 22798 - email: presse@tum.de - web: www.tum.de Video: https://www.youtube.com/watch?v=_xXV0mCke1g NEWS RELEASE Nanoswitches for tumor targeting TUM spin-off Plectonic develops antibody-based immunotherapies Plectonic Biotech, a spin-off of the Technical University of Munich (TUM), has developed a nanoswitch that binds immune cells to tumor cells. The goal is to facilitate the development of ...
more
Flu tests from R-Biopharm also detect new virus variants
moreEuropean lemon, the unexpected ingredient to get all the juice out of Thanksgiving dinner
moreGerman Bionic Cray X exoskeleton receives “Best of Innovation” distinction at the CES 2023 Innovation Awards
moreTechnische Universität München
Tumors: forecasting the risks of brain surgery
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 18198 - email: presse@tum.de - web: www.tum.de This text on the web: http://go.tum.de/619311 Pictures: http://go.tum.de/010709 - http://go.tum.de/959985 - http://go.tum.de/098359 - http://go.tum.de/754050 - http://go.tum.de/109729 Accurately predicting possible post-surgical effects on speech Tumors: forecasting the risks of brain surgery ...
moreStem cell therapy for “Butterfly disease” / RHEACELL receives ‘Partners in Progress Award’ from debra of America for Epidermolysis Bullosa research
moreTechnische Universität München
Alzheimer's disease and type 2 diabetes: Synthetic peptides may suppress formation of harmful amyloid aggregates
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22779 - email: presse@tum.de - web: www.tum.de Image download: https://mediatum.ub.tum.de/652209?show_id=1691364 NEWS RELEASE Alzheimer's disease and type 2 diabetes: Synthetic peptides may suppress formation of harmful amyloid ...
more
- 5
Press Release - hubergroup India supports rural areas with medical vans
One documentmore VectorBuilder Raised $57 Million for Gene Delivery R&D
moreVectorBuilder raised $57 million for gene delivery R&D
moreCitrus season begins in the northern hemisphere: the “King of Lemons” returns to the markets
moreThe citrus season is starting / The best way to prepare your body for the cold days
Madrid, Spain (ots) - Hot summer days are gone. With the arrival of cold weather there is nothing better than preparing our body to resist the winter with an iron health The nutritional properties of citrus fruits, with their high antioxidant capacity and Vitamin C content, are perfect for keeping our defences up Their characteristics are perfect to meet the ...
moreMetrics in Balance und DNA Talks schließen sich zusammen und betreten den europäischen Lifestyle-Markt unter einem neuen Namen: LifeTalks
more